Overview


H.R.7839: Continuing Access to In-Home IVIG Act


    About the Bill
  • Continuing Access to In-Home IVIG Act This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease. read more
  • Sponsor and Status
  • Cosponsors
    History
  • Introduced 29 July, 2020
  • Passed House Pending
  • Passed Senate Pending
  • Signed by President No Veto
  • Enacted Pending
  • Users Votes Chart
    No user votes have been made on this bill yet.
    Representatives Votes Chart
    No house representatives votes have been made on this bill yet.
    No senate representatives votes have been made on this bill yet.